Targeting DKK1 enhances the antitumor activity of paclitaxel and alleviates chemotherapy-induced peripheral neuropathy in breast cancer

MLA

Hong-Xiang Shi, et al. “Targeting DKK1 Enhances the Antitumor Activity of Paclitaxel and Alleviates Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer.” Molecular Cancer, vol. 23, no. 1, July 2024, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s12943-024-02067-y.

APA

Hong-Xiang Shi, Hang-Tian Tao, Jin-Jin He, Feng-Yi Zhu, Cui-Qing Xie, Yu-Na Cheng, Li-Li Hou, Hua Sun, Chang-Jiang Qin, Dong Fang, & Song-Qiang Xie. (2024). Targeting DKK1 enhances the antitumor activity of paclitaxel and alleviates chemotherapy-induced peripheral neuropathy in breast cancer. Molecular Cancer, 23(1), 1–7. https://doi.org/10.1186/s12943-024-02067-y

Chicago

Hong-Xiang Shi, Hang-Tian Tao, Jin-Jin He, Feng-Yi Zhu, Cui-Qing Xie, Yu-Na Cheng, Li-Li Hou, et al. 2024. “Targeting DKK1 Enhances the Antitumor Activity of Paclitaxel and Alleviates Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer.” Molecular Cancer 23 (1): 1–7. doi:10.1186/s12943-024-02067-y.